Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

COSMED COMPANY ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024 2025/3 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   6.9% 4.6% 10.2% 8.7% 13.5% 10.5% 20.6% 20.4%   Credit score (0-100)   36 46 23 27 16 23 5 5   Credit rating   BBB BBB BB BB BB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024 2025/3 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,234 1,026 418 314 190 177 0.0 0.0   EBITDA   668 454 -105 -59.0 -186 -77.0 0.0 0.0   EBIT   668 453 -110 -64.3 -191 -86.8 0.0 0.0   Pre-tax profit (PTP)   666.3 447.6 -108.4 -64.4 -199.2 -99.5 0.0 0.0   Net earnings   510.4 342.1 -86.6 -51.6 -156.7 -117.7 0.0 0.0   Pre-tax profit without non-rec. items   666 448 -108 -64.4 -199 -99.5 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024 2025/3 2025e N/A 2026e N/A Tangible assets total   0.0 25.8 20.4 15.1 9.8 0.0 0.0 0.0   Shareholders equity total   772 614 228 176 19.2 20.0 -105 -105   Interest-bearing liabilities   6.1 8.1 7.6 56.3 167 189 105 105   Balance sheet total (assets)   1,197 875 368 411 314 315 0.0 0.0   Net Debt   -670 -388 -84.8 -95.1 77.4 44.4 105 105     See the entire balance sheet 1000.0 Volume  2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024 2025/3 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,234 1,026 418 314 190 177 0.0 0.0   Gross profit growth   3.2% -16.9% -59.2% -24.8% -39.4% -6.8% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,197 875 368 411 314 315 0 0   Balance sheet change%   -23.4% -26.9% -57.9% 11.7% -23.5% 0.4% -100.0% 0.0%   Added value   668.1 454.0 -104.8 -59.0 -185.8 -77.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 25 -11 -11 -11 -20 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   4.0 5.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0   1000.0 Profitability  2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024 2025/3 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   54.1% 44.2% -26.4% -20.5% -100.4% -48.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   48.9% 44.3% -17.1% -16.3% -52.7% -27.6% 0.0% 0.0%   ROI %   77.2% 65.2% -24.5% -27.0% -91.4% -43.9% 0.0% 0.0%   ROE %   58.9% 49.4% -20.6% -25.6% -160.7% -600.5% 0.0% 0.0%   1000.0 Solidity  2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024 2025/3 2025e N/A 2026e N/A Equity ratio %   64.5% 70.2% 61.8% 42.8% 6.3% 6.3% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -100.3% -85.4% 80.9% 161.2% -41.6% -57.6% 0.0% 0.0%   Gearing %   0.8% 1.3% 3.3% 32.0% 869.4% 946.1% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   118.8% 152.0% 27.8% 2.6% 7.2% 7.1% 0.0% 0.0%   1000.0 Liquidity  2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024 2025/3 2025e N/A 2026e N/A Quick Ratio   2.4 2.9 1.9 1.3 0.8 0.8 0.0 0.0   Current Ratio   2.8 3.3 2.6 1.7 1.0 1.1 0.0 0.0   Cash and cash equivalent   676.5 395.6 92.4 151.4 89.4 144.8 0.0 0.0   1000.0 Capital use efficiency  2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024 2025/3 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   772.0 594.0 211.6 160.8 9.4 20.0 -52.5 -52.5   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024 2025/3 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   668 454 -105 -59 -186 -77 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   668 454 -105 -59 -186 -77 0 0   EBIT / employee   668 453 -110 -64 -191 -87 0 0   Net earnings / employee   510 342 -87 -52 -157 -118 0 0